Skip to content

Trial · Interventional

CompletedNot applicableRegistry data

Hemodynamic and Headache-Inducing Effect of Intravenous Vasoactive Intestinal Peptide in Migraineurs

NCTNCT00272896 (opens ClinicalTrials.gov in a new tab)Other idKA04119
Open at ClinicalTrials.govAsk about this trial

Overview

Status
Completed
Phase
Not applicable
Enrollment
12 participants
Sponsor
Danish Headache Center · Other
Design
Randomized · Double masking
Countries
1 country

Denmark

Start
Oct 2004
Primary completion
Not stated
Completion
Sept 2005
First posted
9 Jan 2006 (estimated)
Last update posted
9 Jan 2006 (estimated)
Conditions
Headache · Migraine · Vasoactive Intestinal Peptide · Ultrasonography, Doppler, Transcranial

Timeline

1 trial · 1 completed

  • Completed
  • Ongoing
  • Not yet recruiting
  • Stopped
  • Estimated dates (est.)
  • Results posted
200420052006
  1. N/A

    Hemodynamic and Headache-Inducing Effect of Intravenous Vasoactive Intestinal Peptide in Migraineurs

    NCT00272896

    Oct 2004 to Sept 2005

Registry summary

Text and fields below are the sponsor's entries at ClinicalTrials.gov, shown as posted.

We hypothesized that infusion of VIP may induce headache/migraine in migraineurs and that VIP-induced headache may be associated with dilation of intra- and extracranial vessels. To test this hypothesis, we performed a double blind placebo-controlled crossover study in migraineurs and studied the effect on headache and cerebral and systemic hemodynamic parameters.

Interventions

  • Vasoactive intestinal peptideDrug

Arms0

The registry lists no arms for this trial.

Primary outcomes2

Outcomes the sponsor listed as primary.

  1. Headache

  2. Intra- and extracranial vasodilation

Secondary outcomes(2)

  1. arterial blood pressure

  2. heart rate

Posted results

Values are shown as posted at ClinicalTrials.gov, with their units. PepBank has not converted, pooled or compared them.

No results are posted for this trial.

Completed trials do not always post results.

Registry data comes from ClinicalTrials.gov. Study results come from studies, not from the registry. How PepBank works

Studies0

Studies that cite this trial.

No study cites this trial.

Eligibility

Who could join, as posted.

Sex
All
Age
from 18 Years up to 40 Years
Healthy volunteers
Not accepted
Inclusion and exclusion criteria, as posted
Inclusion Criteria: * migraineurs Exclusion Criteria: * cerebrovascular disorders, pregnancy, nursing

PepBank is a research reference. Talk to a doctor before you use any peptide.